Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Interferon Beta 1B

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer Healthcare Betaseron (Interferon Beta-1B) Receives Suppl Approval In U.S
    Bayer Healthcare Betaseron (Interferon Beta-1B) Receives Suppl Approval In U.S

    09 May 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471

    FDA
    09 May 2024
    Share Share
    Bayer's Biologic Betaseron (Interferon Beta 1B) Receives Approval in the U.S.
    Bayer's Biologic Betaseron (Interferon Beta 1B) Receives Approval in the U.S.

    02 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471

    FDA
    02 Sep 2022
    Share Share
    Novartis Pharms's Biological Interferon Beta-1B Receives Approval In US
    Novartis Pharms's Biological Interferon Beta-1B Receives Approval In US

    02 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125290

    FDA
    02 Oct 2020
    Share Share
    Bayer Healthcare Pharms's Biological Interferon Beta-1B Receives Approval In US
    Bayer Healthcare Pharms's Biological Interferon Beta-1B Receives Approval In US

    01 Oct 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471

    FDA
    01 Oct 2020
    Share Share
    Novartis reports positive Phase III data for multiple sclerosis drug
    Novartis reports positive Phase III data for multiple sclerosis drug

    03 Sep 2019

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/novartis-ofatumumab-phase-iii/

    CLINICALTRIALSARENA
    03 Sep 2019
    Share Share
    BiocurePharm, Korea Announces Closing of Private Placement
    BiocurePharm, Korea Announces Closing of Private Placement

    28 Feb 2019

    // PRESS RELEASE

    https://www.marketwatch.com/press-release/biocurepharm-korea-bpk-announces-closing-of-private-placement-2019-02-28

    PRESS RELEASE
    28 Feb 2019
    Share Share